Explore the latest in heart failure, including recent guidelines and advances in treatment of HF with reduced and preserved ejection fraction.
This post hoc analysis of the PARADIGM-HF and PARAGON-HF randomized clinical trials assesses the effects of sacubitril/valsartan on all-cause hospitalizations across the spectrum of left ventricular ejection fraction.
This comparative effectiveness study assesses the risk of all-cause mortality, cardiovascular mortality, all-cause hospitalization, and heart failure hospitalization among patients with heart failure with reduced ejection fraction requiring dialysis who receive combined sacubitril-valsartan vs angiotensin-converting enzyme inhibitors or angiotensin receptor blockers.
This cohort study examines risk-adjusted short-term, intermediate-term, and long-term mortality among Medicare fee-for-service beneficiaries hospitalized for heart failure.
This randomized clinical trial investigates the effects of verinurad on exercise capacity and symptoms in patients with heart failure with preserved ejection fraction (HFpEF) and elevated serum uric acid levels.
This cohort study of patients with type 2 diabetes compares the rates of hyperkalemia and renin-angiotensin system (RAS) inhibitor persistence in those who used glucagon-like peptide 1 receptor agonists (GLP-1RAs) or dipeptidyl peptidase 4 inhibitors (DPP-4is).
This study assess the safety and efficacy of a novel, leadless, left ventricular endocardial pacing system for patients at high risk for a cardiac resynchronization therapy upgrade or whose coronary sinus lead placement/pacing with a conventional cardiac resynchronization therapy system has failed.
This randomized clinical trial investigates the effect of dapagliflozin on right ventricular performance and vascular load during exertion in heart failure with preserved ejection fraction (HFpEF).
This genetic association study evaluates the association of genetic variants with atrial fibrillation, cardiomyopathy, and heart failure.
This cohort study evaluates the association between social vulnerability and cardiovascular disease among adults in an urban setting in Haiti.
This prospective observational study investigates mortality rates and predictive risk factors for rheumatic heart disease in 24 endemic low- and middle-income countries and evaluates interventions like corrective valve surgery and valvuloplasty.
This cohort study assesses factors associated with potentially preventable emergency department use by adults receiving maintenance dialysis in Canada.
This cohort study examines the incidence of dialysis and acute kidney injury among Medicare beneficiaries after hospitalization for heart failure.
This cohort study evaluates potential shared pathways between incident heart failure and frailty using large-scale proteomics among participants in the Atherosclerosis Risk In Communities Study.
This meta-analysis assesses whether Black patients with heart failure and reduced ejection fraction respond differently than patients of other races to renin-angiotensin system (RAS) blockade by examining individual patient data from randomized clinical trials.
This systematic review and meta-analysis investigates clinical outcomes and postdischarge treatment after acute coronary syndromes or revascularization among people living with HIV.
This study evaluates the prognostic value of routinely available cardiovascular biomarkers when added to established risk factors in the identification of individuals at high risk for atherosclerotic cardiovascular disease.
Customize your JAMA Network experience by selecting one or more topics from the list below.